The Oncology Institute, Inc. (TOIIW)

Market Cap	197.72M
Revenue (ttm)	393.41M
Net Income (ttm)	-53.01M
Shares Out	75.75M
EPS (ttm)	-0.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,353
Open	0.0506
Previous Close	0.0616
Day's Range	0.0500 - 0.0585
52-Week Range	0.0575 - 0.0680
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2025

About TOIIW

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliati...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2007
• Employees: 825
• Stock Exchange: NASDAQ
• Ticker Symbol: TOIIW
• Website: https://theoncologyinstitute.com

Financial Performance

In 2024, The Oncology Institute's revenue was $393.41 million, an increase of 21.33% compared to the previous year's $324.24 million. Losses were -$53.01 million, -21.91% less than in 2023.